Fiocruz International News - May 2022

Fiocruz will be representing Brazil at the BRICS Vaccine Center
The Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz) will be the Brazilian representative at the BRICS Center for Vaccine Research and Development, with the goal of sharing experiences, information and training
Foundation and DNDi seal a strategic alliance and a partnership against dengue fever
In addition to the signing of a Memorandum of Understanding, the occasion sealed Strategic Research Alliance and the submission of a project to the Finep Public Notice for Neglected Diseases
Project for a new malaria vaccine receives Japanese support
In partnership with Tropical Medicine Foundation, institutions from Japan and the United Kingdom, Fiocruz Amazônia participates in a pre-clinical research project for a vaccine against the vivax variety of malaria
Research evaluates the effectiveness of four immunizing in cases of reinfection by COVID-19
Published in the Lancet Infectious Diseases journal, a Fiocruz study demonstrates that even people previously infected with Sars-CoV-2 have increased levels of protection when vaccinated
Fiocruz promotes activities for the World Chagas Disease Day
Events online held by the Foundation and the launch of a series of articles mark the date of April 14. Some actions involve other countries, such as Cuida Chagas Project, developed with Colombia, Paraguay and Bolivia
Danish delegation, Inpi and Foundation discuss innovation in Health
Representatives of the Danish government and the National Institute of Industrial Property (Inpi) visited Fiocruz as part of cooperation activities for innovation in Health between Brazil and the European country
Meeting celebrates a victorious partnership that received an international award
Project 'Digital technology and social participation in surveillance and definition of priority areas and actions for the control of yellow fever in Brazil is the result of a partnership between Fiocruz, the Ministry of Health and the Paraná and São José dos Pinhais Health Departments
Unitaid and Fiocruz are going to implement injectable PrEp against HIV in Brazil
With just six injections per year, the method proved to be more effective than daily oral PrEP in reducing the risk of infection with the virus. The announcement was made during the Fiocruz-Unitaid symposium